Article

Microcoaxial torsional phaco method of choice

The vast majority of ophthalmologists are going to become convinced that 2.2 mm microcoaxial surgery with Ozil (Alcon) phaco must be the method of choice for both surgeons and patients said Dr Robert Osher.

The vast majority of ophthalmologists are going to become convinced that 2.2 mm microcoaxial surgery with Ozil (Alcon) phaco must be the method of choice for both surgeons and patients said Dr Robert Osher.

Dr Osher, who is working with a new proprietary Ozil programme, told delegates that there is very little turbulence with the Ozil. "There is an enormous amount of efficiency and it is thermal protected. Not only is there additional thermal protection for the sleeve but, because of the slope of the tip, there's 20% less temperature in the incision."

Again, Dr Osher was discussing a proprietary tip that is due to become available shortly. "Normally I prefer a straight tip, but I've switched to this because the torsional technique needs some slope and it reduces temperatures."

He noted that there is no learning curve with microcoaxial phaco, however there is a learning curve for lens injection. "Once you learn the technique it is incredibly safe, effective and reliable," he said.

"It takes faith to get a lens through an un-enlarged 2.2 mm incision, but they offer stable chambers and reduction of turbulence that convinces me that this is the best operation available for my patients."

To prove his point, Dr Osher showed a video procedure of a patient with segmental iris dysgenesis. "There's no stroma, only pure pigment, which will be liberated in the chamber if there's any turbulence at all, and as you can see, there's no pigment liberated. What better demonstration of the gentleness of this procedure."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.